Imperagen Raises £5M for Enzyme Engineering
Business
⚠ Single-source●○○
64d ago

Imperagen Raises £5M for Enzyme Engineering

AI-synthesized · Bias removed · Facts only

Biotech company Imperagen announced on Thursday that it has successfully raised £5 million, equivalent to $6.7 million, in a new seed funding round. The financing was led by PXN Ventures, with significant participation from IQ Capital and Northern Gritstone.

The company focuses its efforts on the field of enzyme engineering. To advance its work in this area, Imperagen intends to utilize sophisticated techniques involving quantum physics and artificial intelligence (AI). This seed round marks a notable step for the company as it seeks to apply these advanced technologies to its biotech operations.

Was this useful?

How we processed this story

  • ✓ Neutralized — Loaded language, emotional intensifiers, and editorial framing were stripped from the original coverage. Direct quotes are preserved verbatim. The change log is available on request.
  • ● Coverage — Three dots show whether left, center, and right outlets in our pool covered this story. Filled means yes, hollow means no. One-sided coverage is shown honestly — we don't hide it, and we don't penalize it.
  • ⚠ Wire — Flagged when "multiple" outlets are reprinting the same wire-service copy. Several reprints of one AP story are not three independent perspectives.

We don't rate truth. We strip the spin and show you which perspectives covered the story. You decide.

Read the original coverage

◀ Left Techcrunch Read original ↗

💬 Comments

📜 Comment Policy